The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
« Previous Page | Next Page »Part II: Subject File, 1902-2012Navigate Contents List
Access restrictions apply.Some or all content stored offsite.
ContainerContents
Part II: Subject File, 1902-2012 (continued)
BOX II:170 Maternal-Child Problems Task Force See also Container II:100, Bendectin
BOX II:170 1979-1981
(6 folders)
BOX II:170 1982
(1 folder)
BOX II:171 (2 folders)
BOX II:171 1983, 1996, undated
(3 folders)
BOX II:171 Memoranda of understanding
BOX II:171 Defense Department, investigational new drugs, 1969, 1974-1981, 1986-1987, 1997-1998
(2 folders)
BOX II:171 General, 1971-1975, 1982-1988, 1998, undated
BOX II:171 National Institutes of Health, 1975-1981
BOX II:172 New York Department of Health, 1978-1979
BOX II:172 Veteran’s Administration, 1977-1984
BOX II:172 Mercury, 1968-1987, 1996, undated
BOX II:172 Methadone monitoring, 1971-1990, 1999, undated
(5 folders)
BOX II:173 Methotrexate, 1948-1972, 1978, undated See also Container II:98, Antimetabolites/anticancer
(3 folders)
BOX II:173 Methyl CCNU (Drug) See Containers II:180-II:182, National Cancer Institute
BOX II:173 Mifeprex (mifepristone), 2000
BOX II:173 Mintz, Morton, 1966, 1996
BOX II:173 Miscellany
BOX II:173 Chronological
BOX II:173 1961-1973
(6 folders)
BOX II:174 1974-1979
(8 folders)
BOX II:174 1980
(1 folder)
BOX II:175 (1 folder)
BOX II:175 1981-1983
(6 folders)
BOX II:176 1984-1994
(11 folders)
BOX II:177 1995-2001
(8 folders)
BOX II:178 2002, undated
(2 folders)
BOX II:178 Fragments, undated
BOX II:178 Clippings
BOX II:178 1951-1999
(6 folders)
BOX II:179 2000-2002, undated
(4 folders)
BOX II:179 Fragments, 1955, 1966-1974, 1983-1986, 1997-2001
BOX II:179 Misconduct in science
BOX II:179 Public Health Service initiatives and procedures, 1983-1988
BOX II:179 Reports to the Office of Management and Systems, 1982-1983, 1997-1999
(1 folder)
BOX II:180 (1 folder)
BOX II:180 Modell, Walter, 1959, 1967-1971, undated
BOX II:180 Monensin See Container II:139, Eli Lilly and Co. Task Group
BOX II:180 Monosodium glutamate (MSG), 1967-1973, 1996, undated
BOX II:180 Moulton, Barbara, 1963-1965, 1980, 1996-2000, undated
BOX II:180 Multivitamins, circa 1951, 1962-1963. 1972, 1980-2001
BOX II:180 National Cancer Institute
BOX II:180 1964-1980
(3 folders)
BOX II:181 1981
(6 folders)
BOX II:181 1982
(1 folder)
BOX II:182 (1 folder)
BOX II:182 1983-1985, 1992-1997, undated
(2 folders)
BOX II:182 National Center for Toxicological Research Protocol Task Force, 1966-1972, 2000
BOX II:182 National Institutes of Health
BOX II:182 National Institute of Mental Health
BOX II:182 Death of subject, 1980-1981, 1997-1999
BOX II:182 Principal Investigators of Early Clinical Drug Evaluation Units, meeting minutes, 1961-1962
BOX II:182 Perinatal study See Container II:196, Foundation for Medical Research Perinatal Study
BOX II:182 Representatives of the U.S. Food and Drug Administration on study sections, 1963-1965, undated
BOX II:182 Neonatal pharmacology, 1960-1982, undated
(2 folders)
BOX II:182 Nester, John O., circa 1992-2000
BOX II:183 New Drug Application (NDA) Preservation Committee
BOX II:183 General, 1962-1964, 1982, 1992-2001, undated
BOX II:183 Lists of NDAs reviewed by Kelsey, undated
BOX II:183 Lists of NDAs (1938-1948) to be transferred to National Archives, Washington, D.C., 1995-1996
BOX II:183 Printout of NDAs approved from 1949, Jan. 1 to 1956, Dec. 31, 1995
BOX II:183 New Drug Evaluation Office, U.S. Food and Drug Administration
BOX II:183 Associate director, 1977-1982, 2001
(2 folders)
BOX II:184 Committee to Update the Management Information System, 1982-1983
BOX II:184 Deputy associate director, 1980-1982
BOX II:184 General, 1976-1983
BOX II:184 Minutes of division director meetings, 1980-1984
(2 folders)
BOX II:184 Project Management Systems, implementation session, 1980
BOX II:184 New uses for approved drugs See Container II:208, “Use of Drugs for Unapproved Indications: Your Legal Responsibility”
BOX II:184 Nishimura, Hideo
BOX II:184 General, 1966-1969, 1976, 1996-2000
BOX II:184 Writings, 1968-1975, 1983
BOX II:184 Nurses’ responsibilities in clinical investigations, undated
BOX II:184 Nutritional aspects, 1968-1974, 1981, undated
BOX II:185 Office of Planning Evaluation, studies, 1978-1981, 1993
(4 folders)
BOX II:185 Omeprazole, 1989-1990, undated
BOX II:185 Organizational Effectiveness Project, 1970, 1981-1982, undated
(2 folders)
BOX II:185 Orphan drugs, 1973, 1982-1983, 1992, 1998, undated
BOX II:186 Oxsoralen (methoxsalen), 1992-1993
BOX II:186 Pediatric labeling rule, draft, 1997
BOX II:186 PEG-Superoxide Dimutase (PEG-SOD), 1993
BOX II:186 Penicillamine, 1969-1971, 1983-1984, undated
BOX II:186 Pentamidine, 1982-1987, 1996, undated
BOX II:186 Pesticides and environmental hazards, 1950-1984, 1996-1998, undated
(4 folders)
BOX II:186 Phase I trials, 1976-1982
BOX II:186 Phenacetin, 1961-1962, 1980, 1996
BOX II:186 Phenformin, 1979-1980
BOX II:187 Placebos, 1950-2000
(2 folders)
BOX II:187 Placental transmission of drugs, 1962-1973, 1979, undated
BOX II:187 Podophyllin, drug deformities, 1962-1963, 1972, 1984
BOX II:187 Poisonous plants and animals, 1955, 1961-2002, undated
(3 folders)
BOX II:187 Poquil, 1953-1956
BOX II:187 Practolol, 1975, 1996
BOX II:187 Prednisolone, 1968, 1997
BOX II:187 Pregnancy and drug metabolism, 1965-1977, circa 1982, undated
BOX II:188 Pregnancy labeling, 1966-1969, 1975-1983, 1997-2001
BOX II:188 Preludin, drug deformities, 1962, 1973
Next Page »

Contents List